**Core Concept**
Small cell lung cancer (SCLC) is a highly aggressive and rapidly growing neuroendocrine tumor, often requiring multimodal treatment approaches. Radiotherapy plays a crucial role in the management of SCLC, particularly in localized disease.

**Why the Correct Answer is Right**
SCLC is highly radiosensitive due to its rapid cell division rate and lack of DNA repair mechanisms. Radiotherapy can effectively control local tumor growth and alleviate symptoms, improving quality of life. The high sensitivity of SCLC to radiation is attributed to its high mitotic index and the presence of minimal DNA repair mechanisms, making it an ideal candidate for radiotherapy.

**Why Each Wrong Option is Incorrect**
**Option A:** Non-small cell lung cancer (NSCLC) is less radiosensitive compared to SCLC, and its response to radiotherapy is often variable. While radiotherapy can be used in NSCLC, it is not the most effective treatment option.
**Option B:** Squamous cell carcinoma of the lung is a type of NSCLC and is less responsive to radiotherapy compared to SCLC.
**Option C:** Adenocarcinoma of the lung is another type of NSCLC and has a variable response to radiotherapy, making it an incorrect choice.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that SCLC is a highly radiosensitive tumor, and radiotherapy should be considered as a primary treatment modality in localized disease.

**Correct Answer: C. Adenocarcinoma of the lung is another type of NSCLC and has a variable response to radiotherapy, making it an incorrect choice.